Basel, 29 April 2021
The MPP Association submitted input to the Commission consultation on the roadmap for the revision of the EU general pharmaceutical legislation. MPP is fully supportive of the points laid out in the evaluation roadmap, especially regarding the coherence and complementarity with other legislations, including those concerningcombination products and medical devices. MPP also highlighted key aspects to be addressed by the revision in the area of products combining medicinal product and medical devices components and digital technologies. The full input is available in our publications.